Hematology › Forums › Hematology MCQ discussion forum › NEET SS Clinical Hematology 2020 Telegram Group Discussion MCQs › Reply To: NEET SS Clinical Hematology 2020 Telegram Group Discussion MCQs
35. Which of the following is not a factor bypass agent. Factor bypass agents are standard of care for bleeding hemophilia pateints with inhibitor ?
Answer =  Idracizumab
Idarucizumab, sold under the brand name Praxbind, is a monoclonal antibody used as a reversal agent for dabigatran.